Yayınlar & Eserler

Yayın Ağı
Makaleler 7
Tümü (7)
SCI-E, SSCI, AHCI (7)
SCI-E, SSCI, AHCI, ESCI (7)
Scopus (7)

1. Real-world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple-negative breast cancer: A multicenter study by the Turkish Oncology Group

Tunbekici S., Sahin G., Ön S., Oruc A., Eryılmaz M. K., SAKİN A., et al.
International Journal of Cancer , cilt.158, sa.7, ss.1881-1890, 2026 (SCI-Expanded, Scopus)

2. Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis

Guzel H. G., Kivrak Salim D., Kilickap S., Kemal Y., Akosman C., Koseoglu C., et al.
ONCOLOGIST , cilt.31, sa.4, 2026 (SCI-Expanded, Scopus)

3. Efficacy and safety of doxorubicin–ifosfamide versus gemcitabine–docetaxel as first-line therapy in advanced nonuterine leiomyosarcoma: A multicenter real-world study

Tunbekici S., Sahin G., Yuksel H. C., Acar C., Akın I., Aslanhan H., et al.
International Journal of Cancer , cilt.158, sa.6, ss.1703-1712, 2026 (SCI-Expanded, Scopus)

4. Prognostic Impact of Cetuximab-Related Hypomagnesemia and Hypokalemia in RAS/RAF Wild-Type Colorectal Cancer: A Multicenter Study

Güzel H. G., Kıvrak Salim D., Ulukal Karancı E., Acun M., Çatlı M. M., Mordağ Çiçek C., et al.
Cancer Management and Research , cilt.18, ss.1-12, 2026 (SCI-Expanded, Scopus) Creative Commons License

5. Real-world comparison of doxorubicin–ifosfamide versus gemcitabine–docetaxel regimens in metastatic uterine leiomyosarcoma: a multicenter retrospective study

Tunbekici S., Sahin G., Yuksel H. C., Acar C., Akın I., Aslanhan H., et al.
Discover Oncology , cilt.16, sa.1, 2025 (SCI-Expanded, Scopus)

6. Prognostic importance of CD47 expression on survival of colorectal cancer

Aktepe O. H., Kurtulan O., Dama P. E., Yildirim E. C., Terzi A., Kalyoncu S. A., et al.
BMC GASTROENTEROLOGY , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. Impact of Adipokine Expression on Tumor Characteristics and Survival Outcomes in Patients with Renal Cell Carcinoma

Aktepe O. H., Ulasli T., Terzi A., Gundogdu F., Yildirim E. C., Arslan A. M., et al.
Medicina (Lithuania) , cilt.61, sa.9, 2025 (SCI-Expanded, Scopus)
Metrikler

Yayın

7

Yayın (WoS)

7

Yayın (Scopus)

7

Proje

1

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları
SDG 1: AMAÇ 1: YOKSULLUĞA SON
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER